Deutsche Bank Ag\ X Biotech Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in X Biotech Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 30,338 shares of XBIT stock, worth $94,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,338

Holding current value

$94,351

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.8 - $8.25 $115,284 - $250,288	30,338 New	30,338 $119,000
Q2 2022 Aug 11, 2022	SELL	$5.13 - $9.2 $42,445 - $76,120	-8,274 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.64 - $11.71 $8,449 - $11,452	-978 Reduced 10.57%	8,274 $71,000
Q4 2021 Feb 11, 2022	BUY	$10.95 - $16.07 $5,365 - $7,874	490 Added 5.59%	9,252 $103,000
Q3 2021 Nov 04, 2021	SELL	$12.95 - $18.24 $2,771 - $3,903	-214 Reduced 2.38%	8,762 $113,000
Q2 2021 Aug 11, 2021	SELL	$15.83 - $17.84 $4,574 - $5,155	-289 Reduced 3.12%	8,976 $149,000
Q1 2021 May 13, 2021	SELL	$15.92 - $20.3 $13,993 - $17,843	-879 Reduced 8.67%	9,265 $159,000
Q4 2020 Feb 16, 2021	BUY	$15.65 - $19.92 $43,898 - $55,875	2,805 Added 38.22%	10,144 $159,000
Q3 2020 Nov 12, 2020	BUY	$13.97 - $21.16 $10,742 - $16,272	769 Added 11.7%	7,339 $141,000
Q2 2020 Aug 13, 2020	BUY	$10.39 - $16.07 $18,213 - $28,170	1,753 Added 36.39%	6,570 $90,000
Q1 2020 May 14, 2020	SELL	$8.89 - $24.94 $19,024 - $53,371	-2,140 Reduced 30.76%	4,817 $51,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $7,971 - $19,092	957 Added 15.95%	6,957 $128,000
Q3 2019 Nov 14, 2019	SELL	$6.86 - $10.46 $44,994 - $68,607	-6,559 Reduced 52.23%	6,000 $62,000
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $12,386 - $19,970	-1,772 Reduced 12.36%	12,559 $94,000
Q1 2019 May 15, 2019	BUY	$5.05 - $11.62 $72,371 - $166,526	14,331 New	14,331 $157,000
Q4 2018 Feb 14, 2019	SELL	$3.22 - $6.27 $544 - $1,059	-169 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.31 - $4.69 $44,358 - $90,062	-19,203 Reduced 99.13%	169 $0
Q2 2018 Apr 21, 2020	BUY	$4.04 - $5.13 $32,724 - $41,553	8,100 Added 71.86%	19,372 $87,000
Q2 2018 Aug 14, 2018	SELL	$4.04 - $5.13 $101,686 - $129,122	-25,170 Reduced 69.07%	11,272 $49,000
Q1 2018 Oct 18, 2019	BUY	$3.92 - $5.35 $49,462 - $67,506	12,618 Added 52.96%	36,442 $194,000
Q1 2018 May 15, 2018	SELL	$3.92 - $5.35 $85,663 - $116,913	-21,853 Reduced 47.84%	23,824 $126,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $4.66 $103,771 - $123,993	26,608 Added 139.54%	45,677 $179,000
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $78,945 - $97,633	19,069	19,069 $82,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.7M

Call Options Held

200

Put Options Held

12.8K

Black Rock Inc. New York, NY

1.13M
Shares

$3.53 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$3.31 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

455K
Shares

$1.41 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

264K
Shares

$819,553
0.0% of portfolio
Credit Suisse Ag Zurich, V8

248K
Shares

$772,119
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $94.7M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account